1. Academic Validation
  2. 27-Hydroxycholesterol Drives the Spread of α-Synuclein Pathology in Parkinson's Disease

27-Hydroxycholesterol Drives the Spread of α-Synuclein Pathology in Parkinson's Disease

  • Mov Disord. 2023 Aug 18. doi: 10.1002/mds.29577.
Lijun Dai 1 Jiannan Wang 1 Xingyu Zhang 1 Mingmin Yan 1 Lingyan Zhou 1 Guoxin Zhang 1 Lanxia Meng 1 Liam Chen 2 Xuebing Cao 3 Zhaohui Zhang 1 Gaohua Wang 4 Zhentao Zhang 1 5
Affiliations

Affiliations

  • 1 Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.
  • 2 Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • 3 Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • 4 Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China.
  • 5 TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
Abstract

Background: The accumulation and aggregation of α-synuclein (α-Syn) are characteristic of Parkinson's disease (PD). Epidemiological evidence indicates that hyperlipidemia is associated with an increased risk of PD. The levels of 27-hydroxycholesterol (27-OHC), a Cholesterol oxidation derivative, are increased in the brain and cerebrospinal fluid of patients with PD. However, whether 27-OHC plays a role in α-Syn aggregation and propagation remains elusive.

Objective: The aim of this study was to determine whether 27-OHC regulates α-Syn aggregation and propagation.

Methods: Purified recombinant α-Syn, neuronal cultures, and α-Syn fibril-injected mouse model of PD were treated with 27-OHC. In addition, CYP27A1 knockout mice were used to investigate the effect of lowering 27-OHC on α-Syn pathology in vivo.

Results: 27-OHC accelerates the aggregation of α-Syn and enhances the seeding activity of α-Syn fibrils. Furthermore, the 27-OHC-modified α-Syn fibrils localize to the mitochondria and induce mitochondrial dysfunction and neurotoxicity. Injection of 27-OHC-modified α-Syn fibrils induces enhanced spread of α-Syn pathology and dopaminergic neurodegeneration compared with pure α-Syn fibrils. Similarly, subcutaneous administration of 27-OHC facilitates the seeding of α-Syn pathology. Genetic deletion of Cytochrome P450 27A1 (CYP27A1), the Enzyme that converts Cholesterol to 27-OHC, ameliorates the spread of pathologic α-Syn, degeneration of the nigrostriatal dopaminergic pathway, and motor impairments. These results indicate that the Cholesterol metabolite 27-OHC plays an important role in the pathogenesis of PD.

Conclusions: 27-OHC promotes the aggregation and spread of α-Syn. Strategies aimed at inhibiting the CYP27A1-27-OHC axis may hold promise as a disease-modifying therapy to halt the progression of α-Syn pathology in PD. © 2023 International Parkinson and Movement Disorder Society.

Keywords

27-hydroxycholesterol; CYP27A1; mitochondria; transmission; α-Synuclein.

Figures
Products